Related Experiment Video
Updated: Jul 25, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
Diagnostic Prediction of portal vein thrombosis in chronic cirrhosis patients using data-driven precision medicine
Ying Li1, Jing Gao2, Xubin Zheng3
1The First Hospital of Lanzhou University, Lanzhou, China.
Insights
This study developed a data-driven model for diagnosing portal vein thrombosis (PVT) in cirrhosis patients. The SVM-Naïve Bayes-QDA model accurately identifies PVT, improving clinical decisions for chronic liver disease.
Area of Science:
- Hepatology
- Medical Informatics
- Machine Learning
Background:
- Portal vein thrombosis (PVT) is a critical complication in patients with liver cirrhosis.
- Early and accurate diagnosis of PVT is essential for effective patient management.
- Chronic hepatitis liver cirrhosis patients are particularly susceptible to PVT.
Purpose of the Study:
- To develop and validate a data-driven predictive model for diagnosing PVT in chronic liver cirrhosis patients.
- To identify key clinical and laboratory features predictive of PVT.
- To enhance diagnostic accuracy and clinical decision-making for PVT in this population.
Main Methods:
- Utilized data from 816 chronic cirrhosis patients (Lanzhou and Jilin cohorts) for training and validation.
- Employed a stacking ensemble approach combining Support Vector Machine (SVM), Naïve Bayes, and Quadratic Discriminant Analysis (QDA).
- Identified seven shared predictive features: Portal Velocity (PV), Prothrombin Time (PT), Portal Vein Diameter (PVD), Prothrombin Time Activity (PTA), Activated Partial Thromboplastin Time (APTT), age, and Child-Pugh score (CPS).
Main Results:
- The SVM and Naïve Bayes classifiers identified key features for PVT classification.
- The QDA model, trained on seven shared features, showed significant differentiation between PVT and non-PVT cases (AUROC=0.73 in Lanzhou, 0.86 in Jilin).
- The developed QDA model outperformed other machine learning methods in comparative analysis.
Conclusions:
- A comprehensive data-driven model (SVM-Naïve Bayes-QDA) for PVT diagnosis in cirrhotic patients was successfully developed.
- This model enhances clinical decision-making for managing PVT in patients with chronic liver disease.
- The proposed model offers a precise approach to PVT management in the cirrhotic population.
Background:
Portal vein thrombosis (PVT) is a significant issue in cirrhotic patients, necessitating early detection. This study aims to develop a data-driven predictive model for PVT diagnosis in chronic hepatitis liver cirrhosis patients.
Methods:
We employed data from a total of 816 chronic cirrhosis patients with PVT, divided into the Lanzhou cohort (n = 468) for training and the Jilin cohort (n = 348) for validation. This dataset encompassed a wide range of variables, including general characteristics, blood parameters, ultrasonography findings and cirrhosis grading. To build our predictive model, we employed a sophisticated stacking approach, which included Support Vector Machine (SVM), Naïve Bayes and Quadratic Discriminant Analysis (QDA).
Results:
In the Lanzhou cohort, SVM and Naïve Bayes classifiers effectively classified PVT cases from non-PVT cases, among the top features of which seven were shared: Portal Velocity (PV), Prothrombin Time (PT), Portal Vein Diameter (PVD), Prothrombin Time Activity (PTA), Activated Partial Thromboplastin Time (APTT), age and Child-Pugh score (CPS). The QDA model, trained based on the seven shared features on the Lanzhou cohort and validated on the Jilin cohort, demonstrated significant differentiation between PVT and non-PVT cases (AUROC = 0.73 and AUROC = 0.86, respectively). Subsequently, comparative analysis showed that our QDA model outperformed several other machine learning methods.
Conclusion:
Our study presents a comprehensive data-driven model for PVT diagnosis in cirrhotic patients, enhancing clinical decision-making. The SVM-Naïve Bayes-QDA model offers a precise approach to managing PVT in this population.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:10Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Related Concept Videos
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Portal Hypertension